pfizer glp 1 drug pulls out of GLP-1 race after safety concerns Pfizer, Novo Nordisk bidding war
Description
2021;33:e12953
Some early studies have even shown that people on these medicines lost less brain tissue and had a slower drop in their thinking skills
Past studies show that as much as 17% of GLP-1 users may be non-responders to the medication
Read the full study: Helen Michaela de Oliveira MS, Mariano Reynaldo Gallo Ruelas RD, Pandora Eloa Oliveira Fonseca MS, Camilo Andr Viana Diaz MS, Guilherme Oliveira de Paula MS, Pablo Ramon Fruett da Costa MD, Tariq Parker MD, PhD, Kristopher T
Grant RW, Wexler DJ
Mechanism of GLP- 1 Action in T2DM GLP- 1 increases insulin secretion through direct interaction with pancreatic beta cells
